Chloé Albietz
Co-founder & CEO
Bioscibex
Monthey, Switzerland
57 profile visitsSpeaker
Our single-use bioreactor simplifies and accelerates a critical step in producing leading drugs, saving biopharma companies and CDMOs major time and cost.
My organisation
Our single-use bioreactor simplifies and accelerates cell culture with automation and closed systems, accommodating volumes from 30 mL up to 30 L in the same vessel. Designed for a broad range of cells and for the entire product lifecycle (clinical research, process development, manufacturing).
Speaker sessions (1)
Tuesday, 10 December 2024
10:15 - 11:20
Pitch Sessions Healthtech
Location:Pitch Area 1Track:Pitch Session
Experience the forefront of healthtech innovation at EPFL Investor Day!